Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency

Current therapeutic approaches to the treatment of endocrine ophthalmopathy (EOP) are based on nonspecific immunosuppression with glucocorticosteroids (GCs) and radiation therapy of the eye orbits. However, some patients exhibit resistance to the treatment. In a previous study, we have detected high...

Full description

Saved in:
Bibliographic Details
Main Authors: N. Yu. Sviridenko, E. G. Bessmertnaya, I. M. Belovalova, M. S. Sheremeta, D. M. Babaeva, N. M. Malysheva, E. A. Troshina, G. A. Melnichenko
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2022-11-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/2514
Tags: Add Tag
No Tags, Be the first to tag this record!